Teva Fails Over UK Fostair
Court Refuses To Strike Out Chiesi’s Infringement Claims
Following the principle that a generics firm should “clear the way” and resolve issues of patent validity and infringement ahead of launch, Teva has been denied a request to stay or strike out UK infringement claims brought by Chiesi over its Fostair respiratory brand.
